ARCHIVES

Techniclone Wins Patent For Tumor Necrosis Therapy.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

August 30, 2013

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Lifestyle Changes Common After Cancer Diagnosis

August 26, 2005

Committee Discusses Cap On Center Grants, New Guidelines

October 18, 1991

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998